newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics to Participate in the Jefferies Healthcare Conference

TEL AVIV, Israel and NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT) (VBL), a late-clinical stage biotechnology company developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune or inflamm